Allogeneic Cell Therapies
Summit Presentation

Allogeneic Cell Therapies Summit Presentation

Allogeneic Cell Therapies Summit Presentation

Streamline Cell & Gene Therapy Development with High Quality Cellular Materials, In-House Apheresis Capabilities & Multi-Omics Analytical Services

Presented at ACTS
October 26, 2020

 

The quality of initial cellular raw material has a large impact on cell and gene therapy manufacturing and final product performance. This presentation will discuss Discovery Life Sciences’ capability to provide high-quality cellular material for cell and gene therapy manufacturing by integrating in-house apheresis collections across 2,800+ recallable donors with immunophenotyping, high resolution NGS HLA typing, flow cytometry, immune cell isolation and culture services.

 

Ask Your Questions

Have a question related to this presentation? Submit this form and we will get you answers.

 

To propel your projects with The Power of Discovery.™

Contact Us Today

Let us know about your project!

Image